BERGEM·HEALTH
Home › Treatments › Pulmonology
Pulmonology
SPECIALITY · PULMONOLOGY

Pulmonology in Türkiye — COPD, severe asthma biologics, lung cancer workup, EBUS-TBNA

Interventional bronchoscopy, biologics for severe asthma, polysomnography lab, lung cancer workup coordinated with thoracic surgery and oncology.

What you get
  • Pre-arrival pulmonology consultation with HRCT review
  • EBUS-TBNA for accurate lung cancer staging in one visit
  • Biologic therapy for severe eosinophilic asthma
  • Full polysomnography lab and CPAP titration
5 hospitals · 8 pulmonology professors · EBUS-TBNA · sleep lab
SECOND OPINION ONLINE

Second opinion from a pulmonology professor — within 48 hours, free

Send your HRCT, PET-CT, pulmonary function tests or recent biopsy — the professor returns a written second opinion within 48 hours, free of charge.

01
Upload your discharge summary
Discharge summaries, CT/MRI discs (DICOM), histology slides if available. Up to 200 MB.
02
Coordinator reviews
Selects 2–3 professors matched to your diagnosis and stage. Sends them your records.
03
Video consultation
The professor responds online — review of histology, protocol, travel plan if needed.
What to send
  • Discharge summaries from inpatient / outpatient care
  • CT or MRI — original DICOM discs
  • Histology report (if available)
  • Slides or blocks for review (optional)
  • Current therapy list
Request a second opinion
Free. Confidential. Anna Moroz reads every request personally.
10 PROCEDURES

What we treat in pulmonology

Obstructive and interstitial lung diseases, lung cancer workup, sleep medicine and pulmonary hypertension at our partner hospitals.

TREATMENT METHODS

Treatment methods in pulmonology

Interventional bronchoscopy, biologics for severe asthma, pulmonary rehabilitation, sleep medicine, antifibrotic therapy.

EBUS-TBNA
Endobronchial ultrasound for lymph node sampling and lung cancer staging.
3 clinics
Interventional bronchoscopy
Tumour debulking, stenting, cryotherapy.
3 clinics
Cryobiopsy
Transbronchial lung cryobiopsy for ILD diagnosis.
2 clinics
Biologic therapy for severe asthma
Omalizumab, mepolizumab, benralizumab, dupilumab.
4 clinics
Pulmonary rehabilitation
Structured 6–12 week programme with exercise and education.
3 clinics
Pleuroscopy / medical thoracoscopy
Pleural biopsy and therapeutic intervention.
2 clinics
Sleep medicine (CPAP/BiPAP titration)
Full polysomnography lab and mask fitting.
3 clinics
Antifibrotic therapy for ILD
Nintedanib or pirfenidone for IPF; nintedanib for other progressive fibrosing ILD.
3 clinics
PULMONOLOGY · TEAM

Professors you get direct access to

Professors and senior specialists at Memorial, Liv and Akdeniz. Direct contact, no middlemen.

DB
Doç. Dr. Nurgül Bozkurt
Associate Professor of Chest Diseases, Akdeniz University Faculty of Medicine
Akdeniz University Hospital
DD
Doç. Dr. Hülya Dirol
Associate Professor of Chest Diseases, Akdeniz University Faculty of Medicine
Akdeniz University Hospital
DÜ
Doç. Dr. Fatih Üzer
Associate Professor of Chest Diseases, Akdeniz University Faculty of Medicine
Akdeniz University Hospital
DA
Doç. Dr. Engin Aynacı
Pulmonologist, Memorial Bahçelievler Hospital
Memorial Bahçelievler Hospital
Doç. Dr. Nezih Onur Ermerak
Doç. Dr. Nezih Onur Ermerak
Associate Professor of Thoracic Surgery
Memorial Göztepe Hospital
Doç. Dr. Murat Acat
Doç. Dr. Murat Acat
Associate Professor of Chest Diseases
Memorial Göztepe Hospital
Prof. Dr. Hasan Fevzi Batırel
Prof. Dr. Hasan Fevzi Batırel
Professor of Thoracic Surgery
Memorial Göztepe Hospital
Prof. Dr. Dildar Duman
Prof. Dr. Dildar Duman
Professor of Pulmonology
Memorial Göztepe Hospital
Prof. Dr. Bedrettin Yıldızeli
Prof. Dr. Bedrettin Yıldızeli
Professor of Thoracic Surgery
Memorial Göztepe Hospital
Prof. Dr. Aykut Cilli
Prof. Dr. Aykut Cilli
Professor of Pulmonology
Akdeniz University Hospital
Prof. Dr. A. Candan Öğüş, MD
Prof. Dr. A. Candan Öğüş, MD
Professor of Chest Diseases
Akdeniz University Hospital
Prof. Dr. Tülay Özdemir, MD
Prof. Dr. Tülay Özdemir, MD
Professor of Chest Diseases
Akdeniz University Hospital
Prof. Dr. Ömer Özbudak, MD
Prof. Dr. Ömer Özbudak, MD
Professor of Chest Diseases
Akdeniz University Hospital
Prof. MD. Adil Can Güngen
Prof. MD. Adil Can Güngen
Professor of Chest Diseases
İSÜ Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ömer Ayten
Assoc. Prof. MD. Ömer Ayten
Associate Professor of Pulmonology · Interventional Bronchoscopy
Liv Hospital Vadistanbul
Prof. Dr. Levent Dalar, MD
Prof. Dr. Levent Dalar, MD
Professor of Pulmonology
Liv Hospital Vadistanbul
Prof. Dr. Cengiz Özdemir, MD
Prof. Dr. Cengiz Özdemir, MD
Professor of Chest Diseases (Pulmonology)
Liv Hospital Vadistanbul
Dr. Banu Altoparlak, MD
Dr. Banu Altoparlak, MD
Pulmonology Specialist
Memorial Bahçelievler Hospital
DIAGNOSTICS

Pulmonary diagnostics

HRCT, PET-CT, full pulmonary function, EBUS-TBNA, polysomnography — completed within 1–3 days at a single hospital.

High-resolution CT (HRCT)
Gold standard for ILD, bronchiectasis.
30 min
PET-CT
Lung cancer staging and treatment response.
1 day
Spirometry / plethysmography / DLCO
Full pulmonary function testing.
1 hour
Bronchoscopy with BAL
Direct airway visualisation and lavage.
30 min
EBUS-TBNA
Mediastinal lymph node sampling.
1 hour
Polysomnography
Sleep study with full montage.
1 night
Cardiopulmonary exercise test (CPET)
Functional capacity assessment.
1 hour
FeNO (exhaled nitric oxide)
Asthma phenotyping.
15 min
PRICE SNAPSHOT

Pulmonology pricing — Türkiye vs EU/USA

Minimum prices, for reference only. The final cost is calculated individually after the doctors review your records.

Procedure Türkiye EU / USA Savings
Bronchoscopy with biopsy from $1 200 $4 000 – 8 000 −70%
EBUS-TBNA from $2 500 $8 000 – 15 000 −70%
HRCT from $200 $1 000 – 2 000 −80%
PET-CT (whole body) from $800 $3 500 – 7 000 −75%
Polysomnography from $400 $2 000 – 4 000 −80%
Biologic course (3 months, mepolizumab) from $3 500 $12 000 – 20 000 −70%
Pulmonary rehab (6-week programme) from $2 500 $8 000 – 14 000 −70%
Cryobiopsy for ILD from $3 500 $12 000 – 20 000 −70%
The information on this page is for reference only and does not constitute a medical opinion.
Request a precise quote for my case
QUESTIONS

Frequently asked about Pulmonology

I have a lung nodule on CT — what is next?
Size, density, growth and risk factors determine the workup. Very small nodules (<6 mm) often need no follow-up; 6–8 mm nodules are rechecked with low-dose CT; nodules over 8 mm or growing may need PET-CT, then EBUS-TBNA or CT-guided biopsy. All incidentals reviewed by a multidisciplinary team.
Severe asthma — am I a biologic candidate?
Yes if ACQ worsens on triple inhaler, ≥2 exacerbations/year, eosinophils >300 (mepolizumab/benralizumab), IgE-driven (omalizumab) or type-2 high (dupilumab). Decided by phenotyping.
Sleep apnea — surgery or CPAP?
CPAP is first-line for moderate-severe OSA. Surgery is considered if CPAP-intolerant or with anatomic obstruction. DISE (drug-induced sleep endoscopy) determines surgical candidacy.
Will my COPD improve in Türkiye?
Inhaler optimisation, smoking cessation, vaccination, pulmonary rehab and proper inhaler technique can improve breathlessness, exercise capacity and quality of life within weeks, and reduce exacerbation risk over time. Biologic therapy (dupilumab) is offered in selected eosinophilic-COPD cases.
How does interventional bronchoscopy help diagnose and stage early lung cancer?
Linear EBUS-TBNA samples mediastinal lymph node stations 2R, 4R, 4L and 7 for N-staging. Peripheral nodules are sampled by bronchoscopy or CT-guided biopsy, depending on location; the method is chosen by the multidisciplinary team. For nodules under 20 mm, large studies put bronchoscopic diagnostic yield at only about 60–70%, so a non-diagnostic result may still need CT-guided biopsy or surgery.
How is pulmonary hypertension classified and which medications are used?
PH is classified into Groups 1-5 per WHO: PAH (Group 1), left-heart disease (2), lung disease/hypoxia (3), chronic thromboembolic (4), and multifactorial (5). Right heart catheterization confirms mPAP >20 mmHg and PVR >2 WU. PAH-specific triple therapy combines a PDE-5 inhibitor or riociguat, an ERA (macitentan, ambrisentan), and a prostacyclin pathway agent (selexipag, treprostinil); CTEPH may be cured by pulmonary endarterectomy; inoperable cases are treated with balloon pulmonary angioplasty and riociguat.
How is idiopathic pulmonary fibrosis (IPF) diagnosed and treated today?
IPF is diagnosed by HRCT showing a definite or probable UIP (usual interstitial pneumonia) pattern, with surgical or transbronchial cryobiopsy reserved for indeterminate cases, and confirmed by a multidisciplinary discussion. Antifibrotic therapy with nintedanib or pirfenidone slows FVC decline by approximately 50% and is started at diagnosis regardless of severity. Lung transplant referral is initiated when FVC <80% predicted or DLCO <40%, oxygen saturation drops on 6MWT, or acute exacerbation occurs.
REQUEST

Tell me about your case — I’ll read it personally.

Fill in the short form on the consultation page — diagnosis, preferred timing, attached records. We assemble a tumour board for your case and reply within 4 hours.

Open the consultation form
  • Reply within 4 hours during business hours
  • Confidentiality guaranteed
  • Coordinator-translator inside the doctor’s office
  • Tumour board of 2–3 professors within 72 hours